First real success for anti-HIV gel: a new start for HIV microbicides?

被引：6
|
作者：
Arien, Kevin K. [1 ]
Vanham, Guido [1 ]
机构：
[1] Inst Trop Med, Dept Microbiol, Virol Unit, B-2000 Antwerp, Belgium
来源：
FUTURE MICROBIOLOGY | 2010年 / 5卷 / 11期
关键词：
CONTROLLED-TRIAL; DOUBLE-BLIND; TRANSMISSION; PREVENTION; SAFETY; PHARMACOKINETICS; INFECTION; EFFICACY; WOMEN;
D O I：
10.2217/FMB.10.129
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：1621 / 1623
页数：3
相关论文
共 50 条
  • [31] Liposomes as nanocarriers for anti-HIV therapy
    Chopra, Shruti
    Venkatesan, Natarajan
    Betageri, Guru V.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2013, 3 (05) : 471 - 478
  • [32] Sensitivity Analysis of a Pharmacokinetic Model of Vaginal Anti-HIV Microbicide Drug Delivery
    Jarrett, Angela M.
    Gao, Yajing
    Hussaini, M. Yousuff
    Cogan, Nicholas G.
    Katz, David F.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (05) : 1772 - 1778
  • [33] The consequences of yield stress on deployment of a non-Newtonian anti-HIV microbicide gel
    Tasoglu, Savas
    Park, Su Chan
    Peters, Jennifer J.
    Katz, David F.
    Szeri, Andrew J.
    JOURNAL OF NON-NEWTONIAN FLUID MECHANICS, 2011, 166 (19-20) : 1116 - 1122
  • [34] Conjugation of anti-HIV gp41 monoclonal antibody to a drug capable of targeting resting lymphocytes produces an effective cytotoxic anti-HIV immunoconjugate
    Pincus, Seth H.
    Cole, Frances M.
    Ober, Kelli
    Tokmina-Lukaszewska, Monika
    Marcotte, Tamera
    Kovacs, Ernest W.
    Zhu, Tong
    Khasanov, Alisher
    Copie, Valerie
    Peters, Tami
    JOURNAL OF VIROLOGY, 2024,
  • [35] Chitosan Nanoparticles as a New Delivery System for the Anti-HIV Drug Zidovudine
    Dahmane, El Montassir
    Rhazi, Mohammed
    Taourirte, Moha
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2013, 34 (05) : 1333 - 1338
  • [36] Novel Approaches for the Delivery of Anti-HIV Drugs-What Is New?
    das Neves, Jose
    PHARMACEUTICS, 2019, 11 (11)
  • [37] Genital Mucosal Drug Concentrations and anti-HIV Activity in Tenofovir-Based PrEP Products: Intravaginal Ring vs. Oral Administration
    Ouattara, Louise A.
    Thurman, Andrea R.
    Jacot, Terry A.
    Cottrell, Mackenzie
    Sykes, Craig
    Blake, Kimberly
    Fang, Xi
    Ju, Susan
    Vann, Nikolas C.
    Schwartz, Jill
    Doncel, Gustavo F.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 89 (01) : 87 - 97
  • [38] Conjugates of betulin derivatives with AZT as potent anti-HIV agents
    Xiong, Juan
    Kashiwada, Yoshiki
    Chen, Chin-Ho
    Qian, Keduo
    Morris-Natschke, Susan L.
    Lee, Kuo-Hsiung
    Takaishi, Yoshihisa
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (17) : 6451 - 6469
  • [39] The elvitegravir Quad pill: the first once-daily dual-target anti-HIV tablet
    Marchand, Christophe
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (07) : 901 - 904
  • [40] Anti-HIV antibodies: multiple antiviral activities
    Peressin, Maryse
    Holl, Vincent
    Moog, Christiane
    M S-MEDECINE SCIENCES, 2014, 30 (01): : 69 - 75
12345